Zacks Investment Management Care Dx, Inc. Transaction History

Zacks Investment Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$59.15 - $91.99 $943,383 - $1.47 Million	-15,949 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$63.02 - $95.11 $1.52 Million - $2.3 Million	-24,191 Reduced 60.27%	15,949 $1.46 Million
Q1 2021 May 17, 2021	SELL	$57.62 - $95.6 $252,317 - $418,632	-4,379 Reduced 9.84%	40,140 $2.73 Million
Q4 2020 Feb 16, 2021	SELL	$41.43 - $77.09 $111,322 - $207,140	-2,687 Reduced 5.69%	44,519 $3.23 Million
Q3 2020 Nov 16, 2020	SELL	$30.88 - $37.94 $100,761 - $123,798	-3,263 Reduced 6.47%	47,206 $1.79 Million
Q2 2020 Aug 14, 2020	SELL	$18.95 - $35.43 $91,168 - $170,453	-4,811 Reduced 8.7%	50,469 $1.79 Million
Q1 2020 May 15, 2020	SELL	$13.94 - $28.25 $30,932 - $62,686	-2,219 Reduced 3.86%	55,280 $1.21 Million
Q4 2019 Feb 14, 2020	BUY	$19.24 - $28.41 $1.11 Million - $1.63 Million	57,499 New	57,499 $1.24 Million

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.